Dr Ling and colleagues performed a large prospective study, including 308 patients with major trauma, and determined that the genotype distribution of the IL-10 polymorphisms was associated with the sepsis morbidity rate and multiple organ dysfunction syndrome (MODS) scores [1] . Th e authors also investigated the association of polymorphisms with lipopolysaccharide-induced IL-10 production.
Th e authors investigated the hypothesis that SNPs located in the cis-regulatory region of IL-10 promoter might represent a risk factor or a protective factor for developing sepsis and might infl uence the MODS score after major trauma. Th e results obtained by Dr Ling and colleagues demonstrated that both the -1082A and -592A alleles were signifi cantly associated with lower lipopolysaccharide-induced IL-10 production in an allele-dose-dependent fashion. In contrast, there was no signifi cant diff erence for association between the -819 polymorphism and induced cytokine production. Th ese results are in agreement with the data from Turner and colleagues, who found that the IL-10 -1082A allele is associated with lower in vitro IL-10 production by concanavalin-A-stimulated peripheral blood mono nuclear cells from normal subjects [2] . Moreover, Stanilova and colleagues reported that carriage of at least one copy of the IL-10 -1082A allele in sepsis patients as well as in healthy controls resulted in a statistically signifi cant decrease of IL-10 production from stimulated peripheral blood mononuclear cells, regardless of the stimuli used [4] .
Altered host defense mechanisms are considered important for the development of sepsis and septic shock. Proinfl ammatory and anti-infl ammatory responses contribute to the development and outcome of severe sepsis [5] . Cytokines play a pivotal role in the regulation of the type and magnitude of the immune response, and the polymorphic nature of the cytokine genes may confer fl exibility on the immune response. Th e gene encoding IL-10 cytokine involved in the modulation of infl ammatory responses as a main anti-infl ammatory agent is therefore a candidate gene for determination of the human genetic background, which is responsible for inter individual diff erences in susceptibility to sepsis development. Previous reports have indicated that increased IL-10 production might be associated with the susceptibility and outcome of the sepsis [6] [7] [8] . Th e polymorphism at position -1082 in the promoter region of the IL-10 gene has been studied by Shu and colleagues, who reported an association of this polymorphism with susceptibility to severe sepsis -in contrast to the other two linked IL-10 polymorphisms (-592 and -819) in the same gene region [9] . Stanilova and colleagues showed that the A allele of the -1082 polymorphism in the IL-10 gene promoter is associated with sepsis susceptibility, whereas the G allele is asso ciated with higher stimulated IL-10 production and increased mortality in severe sepsis [4] .
Ling and colleagues also showed that, unlike the -1082 polymorphism, the -819 and -592 polymorphisms were not signifi cantly associated with the sepsis morbidity rate and MODS scores. Th ese collective data clearly demonstrated that the -1082 A/G polymorphism in the IL-10 gene has an important impact on susceptibility of sepsis and sepsis outcome. Th is eff ect is due to the antiinfl ammatory and immunoregulatory properties of IL-10. Th e excess of IL-10 production in trauma patients or other critically ill patients determined by the -1082G allele could be responsible for inducing immunosuppression and subse quently developing bacterial sepsis and MODS. Th e concentration of IL-10 in the blood -in most respects, lipopolysaccharide-induced IL-10 -is indicative for the magnitude of the infl ammatory stress during sepsis and has been shown to correlate with both the severity and outcome of sepsis.
Whether cytokine determination and genotyping in critically ill patients could optimize treatment and sepsis outcome should be determined by further randomized studies.
Abbreviations IL = interleukin; MODS = multiple organ dysfunction syndrome; SNP = single nucleotide polymorphism.
